Based in the United States, Velsera is a startup. Brouky records 1 investor associated with the company.
Velsera is a global precision medicine technology company that provides integrated AI-enhanced software and services for clinical genomics implementation, reporting, multi-omic data analysis, and compliance to accelerate discovery and clinical diagnostic scaling.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.